Premier Energies to float IPO, to raise ₹1,500 crore

Premier Energies Limited, an integrated solar cell and solar module manufacturer with an annual installed capacity of 2 GW and 3.36 GW respectively, has filed the draft red herring prospectus (DRHP) with SEBI to raise over ₹1,500 crore through an initial public offering (IPO).

Premier Energies Limited, an integrated solar cell and solar module manufacturer with an annual installed capacity of 2 GW and 3.36 GW respectively, has filed the draft red herring prospectus (DRHP) with SEBI to raise over ₹1,500 crore through an initial public offering (IPO).

Also read:Premier Energies bags ₹1,700-crore order from NTPCThe 29-year-old company, founded by Surender Pal Singh Saluja, said it would utilise the proceeds of the fresh issue in its subsidiary Premier Energies Global Environment Private Limited (PEGEPL). Investments to the tune of ₹1,168 crore would be made for part-financing the establishment of a 4-GW Solar PV TOPCon Cell (Tunnel Oxide Passivated Contac) and 4-GW Solar PV TOPCon Module manufacturing facility in Hyderabad.

The IPO would consist of a fresh issue of equity shares aggregating up to ₹1,500 crore and an offer for sale of up to 2.82 crore shares by the selling shareholders.

“Under the offer for sale component, South Asia Growth Fund II Holdings LLC will divest 2.38 crore and South Asia EBT Trust will divest 1.53 lakh shares and promoter Chiranjeev Singh Saluja will sell 42 lakh shares,” the DRHP said.

The company might go for a pre-IPO placement of specified securities for up to ₹300 crore. “If the pre-IPO placement is undertaken, the fresh issue will be reduced to the extent of such pre-IPO placement,” the company said.

Premier Energies, which has five manufacturing facilities in Hyderabad, has become the largest Indian exporter of solar cells to the United States for the nine months ended December 31, 2023.

Also read:IEX awaits regulatory approval to launch derivativesThe company posted revenue from operations of ₹1,428 crore in the financial year 2022-23. In the first nine months, it registered revenue from operations of ₹2,017 crore for the nine-month period ended December 31, 2023.

“As of March 15, 2024, the company had an order book of ₹5,362 crore,” it said.

Like (0)
Previous April 19, 2024 7:39 pm
Next April 22, 2024 4:17 pm

Related posts

  • EaseMyTrip, SIDBI, Uttarakhand Tourism jointly offer homestay entrepreneurship training

    EaseMyTrip.com, in collaboration with the Small Industries Development Bank of India (SIDBI) and the Uttarakhand Tourism Development Board (UTDB), announced the launch of a homestay entrepreneurship training programme along the Chardham Yatra route.

    US stock news May 14, 2024
  • EV start-up EMotorad ends FY24 with 370% growth in domestic market

    EMotorad, a leading domestic premium electric cycle brand, has experienced a remarkable growth rate of over 370 per cent in India during FY24, with its customer base now exceeding 100,000 globally.

    US stock news April 19, 2024
  • Indivior fell nearly 5% before the market opened. Q1 results fell short of expectations.

    Gelonghui, April 25 | Indivior (INDV.US) fell 4.84% to US$17.9 before the opening. According to the news, the company’s Q1 financial report achieved revenue of US$284 million, compared with the previous value of US$253 million, which was lower than the market expectation of US$299.8 million; earnings per share was US$0.37, compared with the previous value of US$0.40, which was lower than the market expectation of US$0.41.

    US stock news April 25, 2024
  • Released the first \”Low Carbon Medical Action Guidelines\”, Yingkang Life Insurance further promotes low carbon operations

    Recently, the \”Seventh Hospital Logistics Development Conference and Hospital Logistics Equipment, Technology and Service Exhibition\”, guided by the Hospital Construction and Equipment Branch of the China Medical Equipment Association and sponsored by Zhuyi Tai, was officially held. The conference aims to improve the sophistication of the overall hospital operations. and informatization to help build smart hospitals, safe hospitals, and green hospitals. At the scene, Yingkang Life, a listed company under Haier Group\’s big health ecological brand Yingkang Life, released the \”Low Carbon Medical Action Guidelines\”. According to industry experts, this is the first action guideline for the mainland medical industry to integrate low-carbon and medical care. Hospitals are an important area of ​​medical carbon footprint and an important scenario for achieving medical carbon peak and carbon neutrality. According to \”HEALTH CARE`S CLIMATE FOOTPRINT\” released by Harmless Medical, the carbon footprint of the medical sector in various countries around the world accounts for an average proportion of national carbon emissions of 4.4%. The top ten medical system emitters account for 75% of the total global health care emissions. China ranks second…

    US stock news April 25, 2024
  • Yuxin Shares: Net profit in the first quarter of 2024 was 73.0692 million yuan, a year-on-year decrease of 31.78%

    CSI Intelligent Finance Yuxin Co., Ltd. (002986) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 1.818 billion yuan, a year-on-year increase of 22.87%; net profit attributable to the parent company was 73.0692 million yuan, a year-on-year decrease of 31.78%; non-net profit after deduction was 70.5921 million yuan, a year-on-year decrease of 31.83%; Net cash flow was -223 million yuan, compared with 10.0263 million yuan in the same period last year; during the reporting period, Yuxin\’s basic earnings per share was 0.1948 yuan, and the weighted average return on net assets was 1.92%.

    US stock news April 25, 2024
  • Witten Electric (688226.SH): Net profit in 2023 is 120 million yuan, a year-on-year increase of 72.3%

    Gelonghui April 25丨Weiteng Electric (688226.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 2.848 billion yuan, an increase of 74.03% over the same period last year; net profit attributable to shareholders of listed companies 120 million yuan, an increase of 72.30% compared with the same period last year. In 2023, due to the implementation of the restricted stock incentive plan, the company listed share-based payment expenses. If the impact of this matter is excluded, the net profit attributable to shareholders of the listed company increased by 87.37% compared with the same period last year. At the same time, the company optimized its business layout and continued to increase investment in the development of new products. During the reporting period, R&D expenses were 91.9851 million yuan, an increase of 54.74% from the previous period. It is planned to distribute a cash dividend of 2.34 yuan (tax included) to all shareholders for every 10 shares.

    US stock news April 25, 2024